Effect of process variables on the preparation of BSA loaded double-walled poly(lactide-co-glycolide) microspheres

Biodegradable poly(lactide-co-glycolide) (PLGA) microspheres have received much attention over the last twenty-five years for controlled parenteral delivery of therapeutic protein and peptide drugs [1, 2]. In general, for protein drugs delivery, PLGA and PLGA-based single-polymer microspheres system...

Full description

Bibliographic Details
Main Authors: Rahman, Md. Mokhlesur, Ansary, R.H., Mohamed, Farahidah, Kasmuri, Abdul Razak, Md. Aris, Mohd. Aznan, Katas, H, Awang, M.B.
Format: Conference or Workshop Item
Language:English
English
Published: 2016
Subjects:
Online Access:http://irep.iium.edu.my/52222/
http://irep.iium.edu.my/52222/2/participation%20Cert.%20scan.jpg
http://irep.iium.edu.my/52222/13/52222.pdf
Description
Summary:Biodegradable poly(lactide-co-glycolide) (PLGA) microspheres have received much attention over the last twenty-five years for controlled parenteral delivery of therapeutic protein and peptide drugs [1, 2]. In general, for protein drugs delivery, PLGA and PLGA-based single-polymer microspheres system still suffer from two major technical problems associated with their inherent stability problem [3]. Initial burst release followed by very slow and incomplete release is one of the most serious problems in the formulation of PLGA-based protein drugs delivery system. Many strategies have been explored currently to reduce the high initial burst release of protein and peptide drugs from PLGA microspheres [4]. Fabrication of double-walled microspheres in which protein drugs encapsulated in the inner core surrounded by a drug free outer polymer layer offers a promising technique in reducing the high initial burst release. In previous studies, large size double-walled microspheres have been prepared using poly(L-lactic acid) (PLLA) and different co-polymers of PLGA (ester-terminated and carboxyl-terminated) as the core and shell material. Double-walled microspheres consisting PLLA and ester-terminated PLGA as the core or shell material required more time for the complete release of encapsulated drugs due to the slow degrading nature of these polymers.